_id
690dae42ccc777a4e85d0a72
Ticker
AMIX
Name
Autonomix Medical, Inc. Common Stock
Exchange
NASDAQ
Address
21 Waterway Avenue, The Woodlands, TX, United States, 77380
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://autonomix.com
Description
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Last Close
0.4653
Volume
139656
Current Price
0.4612
Change
-0.0122
Last Updated
2026-01-20T15:18:53.780Z
Image
data:image/webp;base64,UklGRiYDAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSOUAAAANgGvbtqrmXAGee7qMVO75/59wqajicp8rXOnf6TMiYgKAujtn1yf7u+kSZi3z14ebh7UYKVAGxmhtYOaEUkqMVjZN04Vsq1bNjFpeGtHpTyQsS2GapIH5ZfFKCbEPFqslICSMO1Fg5DmorQSkPIxsfm3KEdByO/AvVC7xAIuCPd0ZTK6bGg2IiWVxwM0Y/Pt7A4xh0lpQyyJ4zDi9E9djeFTbrmkYIpIifyF+YHMssi/LG8LtKOQ4ZFVN6gmkCSKHMzI3o9RQ1nT5o/9ytYoyz6LzUmNX1QNJ4l6Jvw2NEhStZOkCAFZQOCAaAgAA0A8AnQEqQABAAD6lQJhJpiOiITf4DADAFIlsALUhzNm+QP27zWad/kt0JUB6ltsB/HvQZ0LPQA6Sj0AOlp/Yn9ridCUwpAi2z8ZhJKNUNfjxTR56qPPqwcrMxT94Kn5D6esRgEq/yOSVG2i0yuHGhtVIUj8DuaVfCc0l7nqdygVzCiw5464AAP72olE45Pena6u4KS0SK8G349Go3TgAhp+u1GXyckGUKzfMyH4exSvYpRu3sj2BUz5Lh6SSjyL4vYO8vyHzf1Irh0j8u9lsj2MA+jlVi5HfYIxRF1LhBx4UXcXPDtZSijxHBvHabXdhiTjt9bIq2/XRmiJG0LCrQdBhSXQGXkcFYyMRwnsQXeHL4o8M2MfwoedxGh623ndXitVH++c+y6PBSOx8LnU1a42EqqhmjVd0ybmM/4p4hoUBuKh/Mk3dUusbppYsyuflJZJaqrUHE0+rarnebk9Uw4k2mEd+qFH90+mQJe2yEY3dK3pcYlFQImZ+9OKmSkSf7EFQPjKdUe2iUSxgoLL+r3pje7JxDCMt7rwSMHJyp7roCL3sBqzn21UwQLmprglkJQ89VCm2QopP9+myBSbaIpgPiSmn4nv6Cl+l25tA+whCHRVq8jPCD7HfYK4iwQ4db4ST0szw3QC+Y5UA6nACdup8FPz/xtwjXuzwhM2RLQpWXDNnIkP3VrFS8Lwmy5Is8TLNfuXiF+AAAA==
Ipo Date
2024-01-29T00:00:00.000Z
Market Cap
3270094
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.997
Sentiment Sources
1
Rating
4.5
Target Price
6.6
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
2000
Gross Profit
-2000
Operating Expenses
7532000
Operating Income
-7534000
Interest Expense
0
Pretax Income
-7451000
Net Income
-7451000
Eps
-1.3768293897546968
Dividends Per Share
-
Shares Outstanding
6907678
Income Tax Expense
-
EBITDA
-7449000
Operating Margin
-
Total Other Income Expense Net
83000
Cash
7477000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
7893000
Property Plant Equipment
16000
Total Assets
7932000
Payables
842000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1487000
Equity
6445000
Bs_currency_symbol
USD
Depreciation
3000
Change In Working Capital
342000
Cash From Operations
-2668000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2121000
Net Change In Cash
-547000
Cf_currency_symbol
USD
PE
-
PB
0.3872583694026377
ROE
-115.6089992242048
ROA
-93.93595562279374
FCF
-2668000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
7
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
2000
Quarters > 0 > income Statement > gross Profit
-2000
Quarters > 0 > income Statement > operating Expenses
7532000
Quarters > 0 > income Statement > operating Income
-7534000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-7451000
Quarters > 0 > income Statement > net Income
-7451000
Quarters > 0 > income Statement > eps
-1.3768293897546968
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
5411709
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7449000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
83000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7477000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7893000
Quarters > 0 > balance Sheet > property Plant Equipment
16000
Quarters > 0 > balance Sheet > total Assets
7932000
Quarters > 0 > balance Sheet > payables
842000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1487000
Quarters > 0 > balance Sheet > equity
6445000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3337000
Quarters > 0 > cash Flow > depreciation
3000
Quarters > 0 > cash Flow > change In Working Capital
342000
Quarters > 0 > cash Flow > cash From Operations
-2668000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2121000
Quarters > 0 > cash Flow > net Change In Cash
-547000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.3768293897546968
Quarters > 0 > ratios > PB
0.3872583694026377
Quarters > 0 > ratios > ROE
-115.6089992242048
Quarters > 0 > ratios > ROA
-93.93595562279374
Quarters > 0 > ratios > FCF
-2668000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
3000
Quarters > 1 > income Statement > gross Profit
-3000
Quarters > 1 > income Statement > operating Expenses
3421000
Quarters > 1 > income Statement > operating Income
-3421000
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-3337000
Quarters > 1 > income Statement > net Income
-3337000
Quarters > 1 > income Statement > eps
-1.074664203666418
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3105156
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3334000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
84000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
8589000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
8978000
Quarters > 1 > balance Sheet > property Plant Equipment
19000
Quarters > 1 > balance Sheet > total Assets
8997000
Quarters > 1 > balance Sheet > payables
815000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1965000
Quarters > 1 > balance Sheet > equity
7032000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3337000
Quarters > 1 > cash Flow > depreciation
3000
Quarters > 1 > cash Flow > change In Working Capital
342000
Quarters > 1 > cash Flow > cash From Operations
-2604000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
2057000
Quarters > 1 > cash Flow > net Change In Cash
-547000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.074664203666418
Quarters > 1 > ratios > PB
0.20365442935153585
Quarters > 1 > ratios > ROE
-47.454493742889646
Quarters > 1 > ratios > ROA
-37.09014115816383
Quarters > 1 > ratios > FCF
-2604000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
86000
Quarters > 2 > income Statement > cost Of Revenue
48000
Quarters > 2 > income Statement > gross Profit
-48000
Quarters > 2 > income Statement > operating Expenses
3204000
Quarters > 2 > income Statement > operating Income
-3252000
Quarters > 2 > income Statement > interest Expense
46000
Quarters > 2 > income Statement > pretax Income
-3191000
Quarters > 2 > income Statement > net Income
-3191000
Quarters > 2 > income Statement > eps
-1.8064735270390762
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1766425
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3097000
Quarters > 2 > income Statement > operating Margin
-3781.3953488372094
Quarters > 2 > income Statement > total Other Income Expense Net
61000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
9136000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
9609000
Quarters > 2 > balance Sheet > property Plant Equipment
21000
Quarters > 2 > balance Sheet > total Assets
9806000
Quarters > 2 > balance Sheet > payables
676000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1707000
Quarters > 2 > balance Sheet > equity
8099000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3191000
Quarters > 2 > cash Flow > depreciation
48000
Quarters > 2 > cash Flow > change In Working Capital
229000
Quarters > 2 > cash Flow > cash From Operations
-2509000
Quarters > 2 > cash Flow > capital Expenditures
4000
Quarters > 2 > cash Flow > cash From Investing
-4000
Quarters > 2 > cash Flow > cash From Financing
-174000
Quarters > 2 > cash Flow > net Change In Cash
-2687000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.8064735270390762
Quarters > 2 > ratios > PB
0.10058960488949253
Quarters > 2 > ratios > ROE
-39.39992591677985
Quarters > 2 > ratios > ROA
-32.54130124413624
Quarters > 2 > ratios > FCF
-2513000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-29.22093023255814
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
47000
Quarters > 3 > income Statement > gross Profit
-47000
Quarters > 3 > income Statement > operating Expenses
2747000
Quarters > 3 > income Statement > operating Income
-2747000
Quarters > 3 > income Statement > interest Expense
45000
Quarters > 3 > income Statement > pretax Income
-2712000
Quarters > 3 > income Statement > net Income
-2712000
Quarters > 3 > income Statement > eps
-1.4643628509719222
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1852000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2620000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
35000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
11823000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
11932000
Quarters > 3 > balance Sheet > property Plant Equipment
20000
Quarters > 3 > balance Sheet > total Assets
11952000
Quarters > 3 > balance Sheet > payables
232000
Quarters > 3 > balance Sheet > short Term Debt
1132000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2245000
Quarters > 3 > balance Sheet > equity
9707000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2713000
Quarters > 3 > cash Flow > depreciation
47000
Quarters > 3 > cash Flow > change In Working Capital
-53000
Quarters > 3 > cash Flow > cash From Operations
-2301000
Quarters > 3 > cash Flow > capital Expenditures
5000
Quarters > 3 > cash Flow > cash From Investing
-5000
Quarters > 3 > cash Flow > cash From Financing
8974000
Quarters > 3 > cash Flow > net Change In Cash
6668000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.4643628509719222
Quarters > 3 > ratios > PB
0.08799241784279385
Quarters > 3 > ratios > ROE
-27.938601009580715
Quarters > 3 > ratios > ROA
-22.690763052208833
Quarters > 3 > ratios > FCF
-2306000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
183000
Annuals > 0 > income Statement > gross Profit
-183000
Annuals > 0 > income Statement > operating Expenses
11588000
Annuals > 0 > income Statement > operating Income
-11588000
Annuals > 0 > income Statement > interest Expense
176000
Annuals > 0 > income Statement > pretax Income
-11410000
Annuals > 0 > income Statement > net Income
-11410000
Annuals > 0 > income Statement > eps
-6.4609286523216305
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1766000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-11051000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
178000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
9136000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
9609000
Annuals > 0 > balance Sheet > property Plant Equipment
21000
Annuals > 0 > balance Sheet > total Assets
9806000
Annuals > 0 > balance Sheet > payables
676000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1707000
Annuals > 0 > balance Sheet > equity
8099000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11410000
Annuals > 0 > cash Flow > depreciation
183000
Annuals > 0 > cash Flow > change In Working Capital
1240000
Annuals > 0 > cash Flow > cash From Operations
-8258000
Annuals > 0 > cash Flow > capital Expenditures
14000
Annuals > 0 > cash Flow > cash From Investing
-14000
Annuals > 0 > cash Flow > cash From Financing
8800000
Annuals > 0 > cash Flow > net Change In Cash
528000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-6.4609286523216305
Annuals > 0 > ratios > PB
0.10056540313618965
Annuals > 0 > ratios > ROE
-140.88159031979256
Annuals > 0 > ratios > ROA
-116.35733224556395
Annuals > 0 > ratios > FCF
-8272000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
81000
Annuals > 1 > income Statement > gross Profit
-81000
Annuals > 1 > income Statement > operating Expenses
12030000
Annuals > 1 > income Statement > operating Income
-12030000
Annuals > 1 > income Statement > interest Expense
79000
Annuals > 1 > income Statement > pretax Income
-15426000
Annuals > 1 > income Statement > net Income
-15426000
Annuals > 1 > income Statement > eps
-21.093538480050977
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
731314
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-15266000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-3396000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
8608000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
9391000
Annuals > 1 > balance Sheet > property Plant Equipment
16000
Annuals > 1 > balance Sheet > total Assets
9407000
Annuals > 1 > balance Sheet > payables
492000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
1002000
Annuals > 1 > balance Sheet > total Liabilities
1779000
Annuals > 1 > balance Sheet > equity
7628000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-15426000
Annuals > 1 > cash Flow > depreciation
81000
Annuals > 1 > cash Flow > change In Working Capital
79000
Annuals > 1 > cash Flow > cash From Operations
-6648000
Annuals > 1 > cash Flow > capital Expenditures
19000
Annuals > 1 > cash Flow > cash From Investing
-19000
Annuals > 1 > cash Flow > cash From Financing
14410000
Annuals > 1 > cash Flow > net Change In Cash
7743000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-21.093538480050977
Annuals > 1 > ratios > PB
0.044216310540115364
Annuals > 1 > ratios > ROE
-202.2286313581542
Annuals > 1 > ratios > ROA
-163.98426703518655
Annuals > 1 > ratios > FCF
-6667000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
1990000
Annuals > 2 > income Statement > operating Income
-1990000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-1990000
Annuals > 2 > income Statement > net Income
-1990000
Annuals > 2 > income Statement > eps
-0.10588485686921358
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
18794000
Annuals > 2 > income Statement > income Tax Expense
-1990000
Annuals > 2 > income Statement > EBITDA
-1990000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
3
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
865000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
865000
Annuals > 2 > balance Sheet > property Plant Equipment
0
Annuals > 2 > balance Sheet > total Assets
865000
Annuals > 2 > balance Sheet > payables
173000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
221000
Annuals > 2 > balance Sheet > equity
644000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1990477
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
136079
Annuals > 2 > cash Flow > cash From Operations
-1854398
Annuals > 2 > cash Flow > capital Expenditures
2
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
675000
Annuals > 2 > cash Flow > net Change In Cash
-1179398
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.10588485686921358
Annuals > 2 > ratios > PB
13.459305590062112
Annuals > 2 > ratios > ROE
-309.00621118012424
Annuals > 2 > ratios > ROA
-230.0578034682081
Annuals > 2 > ratios > FCF
-1854400
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
13594275
Annuals > 3 > income Statement > operating Income
-13594275
Annuals > 3 > income Statement > interest Expense
218088
Annuals > 3 > income Statement > pretax Income
-13328715
Annuals > 3 > income Statement > net Income
-13328715
Annuals > 3 > income Statement > eps
-0.7092005427264021
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
18794000
Annuals > 3 > income Statement > income Tax Expense
-13594000
Annuals > 3 > income Statement > EBITDA
752447
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
265560
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
2044016
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2052747
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
2052747
Annuals > 3 > balance Sheet > payables
91622
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
93242
Annuals > 3 > balance Sheet > equity
1959505
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-13328715
Annuals > 3 > cash Flow > depreciation
13594275
Annuals > 3 > cash Flow > change In Working Capital
204414
Annuals > 3 > cash Flow > cash From Operations
-387307
Annuals > 3 > cash Flow > capital Expenditures
3
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
2430186
Annuals > 3 > cash Flow > net Change In Cash
2044016
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.7092005427264021
Annuals > 3 > ratios > PB
4.423460414747602
Annuals > 3 > ratios > ROE
-680.2082668837282
Annuals > 3 > ratios > ROA
-649.3111425811364
Annuals > 3 > ratios > FCF
-387310
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
38
Valuation > metrics > PE
-1.3768293897546968
Valuation > metrics > PB
0.3872583694026377
Valuation > final Score
70
Valuation > verdict
61.3% Undervalued
Profitability > metrics > ROE
-115.6089992242048
Profitability > metrics > ROA
-94.40010135563158
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.23072148952676494
Risk > metrics > Interest Coverage
-3767
Risk > final Score
-15008
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.374109263657957
Liquidity > metrics > Quick Ratio
9.374109263657957
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-4501
Prev Risks > 1
-223
Prev Risks > 2
-184
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:22:55.312Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-10
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.38
Earnings History > 1 > eps Estimate
-1.5
Earnings History > 1 > eps Difference
0.12
Earnings History > 1 > surprise Percent
8
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-03
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.07
Earnings History > 2 > eps Estimate
-0.98
Earnings History > 2 > eps Difference
-0.09
Earnings History > 2 > surprise Percent
-9.1837
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-29
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.74
Earnings History > 3 > eps Estimate
-1.24
Earnings History > 3 > eps Difference
0.5
Earnings History > 3 > surprise Percent
40.3226
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-13
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.46
Earnings History > 4 > eps Estimate
-2.4
Earnings History > 4 > eps Difference
0.94
Earnings History > 4 > surprise Percent
39.1667
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-08
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-2.47
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-2.47
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-28
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-2.8
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-29
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-2.33
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMarket Outlook: Is AMIX a turnaround story - July 2025 Breakouts & Risk Controlled Stock Pick Alerts baoquankhu1.vn
Read more →Autonomix Medical receives Nasdaq notice for minimum bid price deficiency By Investing.com Investing.com South Africa
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$6.6
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Autonomix Medical, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0
Date
2025-09-30
EPS Actual
-1.38
EPS Estimate
-1.5
EPS Difference
0.12
Surprise Percent
8%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.